Group One Trading
CBIO

Group One Trading’s Crescent Biopharma CBIO Stock Holding History

Group One Trading’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4
Closed -$47 – 8032
2025
Q4 		$47 Sell
4
-78
-95% -$994 ﹤0.01% 7940
2025
Q3 		$975 Sell
82
-80
-49% -$1.06K ﹤0.01% 8060
2025
Q2 		$2.62K Sell
162
-82
-34% -$1.74K ﹤0.01% 7327
2025
Q1 		$5.13K Buy
244
+10
+4% +$268 ﹤0.01% 6628
2024
Q4 		$5.82K Sell
234
-146
-38% -$3.98K ﹤0.01% 6351
2024
Q3 		$6.42K Sell
380
-274
-42% -$5.75K ﹤0.01% 5782
2024
Q2 		$18.4K Buy
654
+367
+128% +$38.2K ﹤0.01% 5283
2024
Q1 		$86K Sell
287
-26
-8% -$7.77K ﹤0.01% 4269
2023
Q4 		$73.8K Buy
313
+29
+10% +$4.51K ﹤0.01% 4733
2023
Q3 		$42.6K Sell
284
-257
-48% -$40.5K ﹤0.01% 5253
2023
Q2 		$94.2K Buy
+541
New +$90.7K ﹤0.01% 4688
2023
Q1 		– Sell
-128
Closed -$28.8K – 7468
2022
Q4 		$38.9K Buy
+128
New +$18.9K ﹤0.01% 5181
2021
Q2 		– Sell
-352
Closed -$89.6K – 8292
2021
Q1 		$106K Buy
352
+35
+11% +$12.5K ﹤0.01% 5603
2020
Q4 		$119K Sell
317
-126
-28% -$44.2K ﹤0.01% 4444
2020
Q3 		$136K Buy
+443
New +$169K ﹤0.01% 3956
2019
Q4 		– Sell
-12
Closed -$6.5K – 5270
2019
Q3 		$5K Buy
12
+2
+20% +$1.29K ﹤0.01% 4763
2019
Q2 		$12K Buy
+10
New +$12K ﹤0.01% 4356
2018
Q3 		– Sell
-17
Closed -$27K – 5339
2018
Q2 		$27K Buy
17
+3
+21% +$5.16K ﹤0.01% 4248
2018
Q1 		$23K Sell
14
-55
-80% -$114K ﹤0.01% 4024
2017
Q4 		$116K Buy
+69
New +$91.2K ﹤0.01% 3271

Other funds holding CBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Group One Trading's CBIO Position: Q1 2026 in Review

Group One Trading sold out of Crescent Biopharma (CBIO) in Q1 2026, closing a stake of 4 shares — an estimated $47 sold.

Group One Trading first reported a position in CBIO in Q4 2017 and held it in 20 quarters. The position peaked at $136K in Q3 2020. 63 funds tracked by Wall St. Rank hold CBIO as of Q1 2026.

  • Group One Trading reported no remaining Crescent Biopharma position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 4 Crescent Biopharma shares in Q1 2026, an estimated $47.
  • Group One Trading first reported a position in Crescent Biopharma in Q4 2017 and held it in 20 quarters.
  • Group One Trading's Crescent Biopharma position peaked at $136K in Q3 2020.
  • 63 funds tracked by Wall St. Rank held Crescent Biopharma as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.